BCRX - Company ID 0000882796
BIOCRYST PHARMACEUTICALS INC (BCRX) reported net income of $263.86M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $263.86M | +396.9% |
| FY 2024 | -$88.88M | +60.8% |
| FY 2023 | -$226.54M | +8.3% |
| FY 2022 | -$247.12M | -34.3% |
| FY 2021 | -$184.06M | -0.7% |
| FY 2020 | -$182.81M | -67.9% |
| FY 2019 | -$108.90M | -7.6% |
| FY 2018 | -$101.25M | -53.9% |
| FY 2017 |
BIOCRYST PHARMACEUTICALS INC (BCRX) reported net income of $263.86M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, BIOCRYST PHARMACEUTICALS INC's net income grew from -$56.95M to $263.86M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$65.78M |
| -19.3% |
| FY 2016 | -$55.14M | -28.2% |
| FY 2015 | -$43.02M | +4.8% |
| FY 2014 | -$45.19M | -50.1% |
| FY 2013 | -$30.11M | +23.0% |
| FY 2012 | -$39.08M | +31.4% |
| FY 2011 | -$56.95M | - |